Cite
AB0314 Awareness and Acceptance of Biosimilars by Rheumatologists in Eleven Eu Countries
MLA
P. Audhya, et al. “AB0314 Awareness and Acceptance of Biosimilars by Rheumatologists in Eleven Eu Countries.” Annals of the Rheumatic Diseases, vol. 75, June 2016, p. 1008.1-1008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ab2c3e58401a41d86a191b618bbf6178&authtype=sso&custid=ns315887.
APA
P. Audhya, N. Georgitseas, Jan Marsal, A. Venugopal, C. Agboton, E. Domènech, H. Kellner, S Anwar, M. Cassese, & Peter L. Lakatos. (2016). AB0314 Awareness and Acceptance of Biosimilars by Rheumatologists in Eleven Eu Countries. Annals of the Rheumatic Diseases, 75, 1008.1-1008.
Chicago
P. Audhya, N. Georgitseas, Jan Marsal, A. Venugopal, C. Agboton, E. Domènech, H. Kellner, S Anwar, M. Cassese, and Peter L. Lakatos. 2016. “AB0314 Awareness and Acceptance of Biosimilars by Rheumatologists in Eleven Eu Countries.” Annals of the Rheumatic Diseases 75 (June): 1008.1-1008. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ab2c3e58401a41d86a191b618bbf6178&authtype=sso&custid=ns315887.